financetom
Business
financetom
/
Business
/
Meta to extend ban on new political ads after U.S. election
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta to extend ban on new political ads after U.S. election
Nov 4, 2024 3:22 PM

Nov 4 (Reuters) - Meta Platforms ( META ) will extend

its ban on new political ads after the U.S. election,

maintaining the suspension until later this week, the

Facebook-parent said in a blog post on Monday.

In response to the rampant spread of misinformation during

the previous presidential election, tech firms are maintaining

heightened scrutiny this year.

During the restriction period, Meta will disallow new

political ads. However, previously served ads with at least one

impression before the ban's implementation will continue to run,

albeit with restricted editing options.

Meta maintains its policy from previous years, asserting

that there may not be sufficient time to effectively challenge

fresh claims made in political ads during the election's last

stretch.

Last year, Meta barred political campaigns and advertisers

in other regulated industries from using its new generative AI

advertising products.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Mar 20, 2024
07:37 AM EDT, 03/20/2024 (MT Newswires) -- Hunter C Smith, Chief Financial Officer, on March 19, 2024, sold 15,515 shares in Rhythm Pharmaceuticals ( RYTM ) for $608,498. Following the Form 4 filing with the SEC, Smith has control over a total of 97,939 shares of the company, with 97,939 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465924036319/xslF345X03/tm249308-6_4seq1.xml ...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Mar 20, 2024
March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver cancer. The results bolster the company's efforts to expand the use for the blockbuster drugs that are set to lose their market...
Nevada Exploration Completes Oversubscribed $605,000 Financing
Nevada Exploration Completes Oversubscribed $605,000 Financing
Mar 20, 2024
08:33 AM EDT, 03/20/2024 (MT Newswires) -- Nevada Exploration ( NVDEF ) overnight Tuesday said that it has completed its private placement offering. The company has issued 5.5 million units at $0.11 apiece, for gross proceeds of $605,000, upsized from $550,000 previously reported. Each unit consists of one common share and one common share purchase warrant. Each warrant allows the...
Yerbae Expanding Into Target Stores
Yerbae Expanding Into Target Stores
Mar 20, 2024
08:31 AM EDT, 03/20/2024 (MT Newswires) -- Yerbae Brands Corp. (YERB-U.V), a plant-based energy beverage company, announced Wednesday that it is expanding distribution into Target ( TGT ) locations. This collaboration marks a significant milestone for Yerbae as it brings its 12 oz Energy Line into select Target ( TGT ) stores across the US. We are thrilled to partner...
Copyright 2023-2026 - www.financetom.com All Rights Reserved